Generic Gleevec (Imatinib): Is It as Good as the Brand?

If your doctor has prescribed Gleevec, you may be wondering whether a cheaper generic Gleevec exists, whether it works as well as the brand, and how to get it. The short answer is that yes, a true generic version of Gleevec has been available for years, it is held to the same FDA standards as the brand, and most patients can access it affordably. Yet many people keep paying brand-name prices simply because of confusion about what the generic is and whether it can be trusted.

This guide clears up that confusion. We explain what generic Gleevec is, whether it is as effective as the brand, why it is sometimes still expensive, and the misconceptions that stop people from switching. At QuickRx Specialty Pharmacy, our team helps patients access generic imatinib affordably and handles the paperwork for you. To speak with a specialist, call (917) 830-2525.

Is There a Generic for Gleevec?

Yes. A generic version of Gleevec, called imatinib mesylate, has been available in the United States since 2016, when Gleevec lost its patent protection. Generic imatinib is sold by multiple manufacturers and is widely stocked at pharmacies across the country.

This matters because one of the most common reasons patients overpay is simply not knowing the generic exists. If you have been filling brand-name Gleevec and paying brand-name prices, switching to the generic where appropriate could lower your cost dramatically. To find out what you would pay, call QuickRx at (917) 830-2525.

What Is Generic Imatinib?

Generic imatinib mesylate is the same active ingredient as brand-name Gleevec. According to MedlinePlus, imatinib is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), Philadelphia chromosome-positive acute lymphoblastic leukemia, and several other conditions. It works by blocking the abnormal BCR-ABL protein that signals certain cancer cells to grow.

A generic drug contains the same active ingredient, in the same strength and dosage form, as the brand-name product. The U.S. Food and Drug Administration (FDA) requires generic drugs to be bioequivalent to the brand, meaning they work the same way in the body.

Is Generic Imatinib as Good as Brand-Name Gleevec?

For most patients, yes. Generic imatinib is FDA-approved and must meet the same standards of quality, strength, purity, and effectiveness as brand-name Gleevec. The FDA requires that a generic deliver the same amount of active ingredient into the bloodstream in the same timeframe as the brand.

That said, the choice is a medical decision. Some patients or prescribers prefer to stay on brand-name Gleevec, and a small share of imatinib prescriptions are written as “dispense as written” to keep patients on the brand. Always discuss any switch with your doctor, and check your insurance, since some plans cover one version over the other. The National Cancer Institute is a good source for understanding your treatment options.

Questions About Switching to Generic? We Can Help

917-830-2525

Myths That Stop People From Switching to the Generic

Many patients keep paying more than they need to because of common misconceptions about generic imatinib. Here are the three biggest, and the facts behind them.

Myth 1: “Cheaper means it is not as good.”

This is the most common worry, and it is understandable, but it is not how generics work. A generic is cheaper because the manufacturer did not have to repeat the original research and clinical trials or pay for brand marketing, not because the medicine is weaker. Generic imatinib must contain the same active ingredient and meet the same FDA bioequivalence standards as Gleevec. The lower price reflects competition, not lower quality.

Myth 2: “There is no generic, so I have to pay brand prices.”

A surprising number of patients do not realize generic imatinib has existed since 2016. If you have never been offered the generic, it is worth asking your doctor and pharmacy whether it is appropriate for you. Switching can take your cost from thousands of dollars per month to a fraction of that, and assistance programs can lower it further.

Myth 3: “Generic Gleevec is a biosimilar.”

This is a real and understandable point of confusion, and getting it right matters. Generic imatinib is a true generic, not a biosimilar. The two are not the same thing, and the difference is explained in the next section.

If any of these have been holding you back, our team can walk you through your options at no cost. Call (917) 830-2525 or visit our copay assistance page.

Generic vs Biosimilar: What Gleevec Patients Should Know

You may have heard the term “biosimilar” in cancer care and wondered whether generic Gleevec is one. It is not, and here is the simple reason.

Gleevec (imatinib) is a small-molecule drug. Small-molecule drugs have a precisely defined chemical structure that can be copied exactly, so their lower-cost copies are called generics. A generic is considered identical to the brand in its active ingredient.

Biosimilars, by contrast, are lower-cost versions of biologic drugs, which are large, complex molecules made from living cells (such as certain antibody therapies). Because biologics cannot be copied exactly, their follow-on versions are called biosimilars, which are highly similar but not identical to the original.

Since imatinib is a small molecule, its affordable version is a true generic, not a biosimilar. For more on this distinction, the FDA explains biosimilars and biologics in detail.

Who Makes Generic Imatinib?

Generic imatinib mesylate is produced by several manufacturers, which is part of why prices vary. Companies that have made generic imatinib include Teva, Mylan (now part of Viatris), Apotex, and Sun Pharmaceuticals, among others. Brand-name Gleevec is made by Novartis.

Because different manufacturers price their generic differently, two patients can be quoted very different amounts for the “same” generic drug. This is one reason comparing pharmacies and getting help identifying your best option is worthwhile.

How Much Does Generic Gleevec Cost?

Generic imatinib generally costs far less than brand-name Gleevec, especially at cash-discount prices, though the exact amount varies widely by pharmacy and manufacturer. We cover current pricing in detail, including brand vs generic figures and how to lower your cost to as little as $0, in our dedicated guide.

For the full breakdown, see our guide to Gleevec and imatinib cost. If you would like personal help finding the lowest price and applying any assistance you qualify for, call QuickRx at (917) 830-2525.

Switching From Gleevec to the Generic

If you are currently on brand-name Gleevec and interested in the generic, here are the practical steps:

1. Talk to your doctor. Switching is a medical decision. Your prescriber can confirm whether generic imatinib is appropriate for you.
2. Check your insurance. Some plans prefer or require the generic, while others cover the brand. Your coverage affects what you pay.
3. Compare pharmacy prices. Because generic pricing varies by manufacturer and pharmacy, the same drug can cost very different amounts in different places.
4. Ask about assistance. Whether you stay on brand or switch to generic, financial assistance may lower your cost further. See how QuickRx can help on our Gleevec copay assistance page.

QuickRx can handle the legwork for you, reviewing your coverage, identifying the most affordable option, and applying any savings you qualify for.

Ready to Save on Imatinib?

Start Your Application

Frequently Asked Questions

Is there a generic version of Gleevec?

Yes. Generic imatinib mesylate has been available in the United States since 2016, when Gleevec lost patent protection. It is sold by multiple manufacturers and stocked at pharmacies nationwide.

Is generic imatinib as effective as brand-name Gleevec?

Generic imatinib is FDA-approved and must meet the same standards of quality, strength, and effectiveness as brand-name Gleevec, delivering the same active ingredient to the body in the same way. Some patients or prescribers still prefer the brand, so discuss any switch with your doctor.

Is generic Gleevec a biosimilar?

No. Gleevec (imatinib) is a small-molecule drug, so its lower-cost version is a true generic, not a biosimilar. Biosimilars are follow-on versions of biologic drugs, which are large molecules made from living cells. Because imatinib is a small molecule, it has a true generic that is identical in active ingredient to the brand.

Why is generic imatinib still expensive sometimes?

When generic imatinib first launched in 2016, prices fell more slowly than expected. Pricing also varies widely by manufacturer, so your pharmacy’s quote can differ significantly from a discount-card price. Comparing pharmacies and using assistance programs helps. See our Gleevec cost guide for current figures.

Who manufactures generic imatinib?

Generic imatinib mesylate has been made by manufacturers including Teva, Mylan (Viatris), Apotex, and Sun Pharmaceuticals, among others. Brand-name Gleevec is made by Novartis.

Can I switch from brand-name Gleevec to generic imatinib?

Often yes, but it is a medical decision. Talk with your doctor about whether the generic is appropriate for you, and check your insurance, since plans may prefer one version over the other. QuickRx can help you review your options and costs at (917) 830-2525.

How much can I save by switching to generic imatinib?

Savings vary, but the difference between brand-name Gleevec and generic imatinib can be substantial, often the difference between thousands of dollars per month and a fraction of that at cash-discount prices. Assistance programs can lower costs further, in some cases to $0. See our cost guide for details.

Additional Resources & Support

Get Help With Generic Imatinib:

• 📋 Apply for Gleevec Copay Assistance
• 💲 Gleevec & Imatinib Cost Guide
• 🤝 Apply for Imatinib Financial Assistance
• 📞 Call: (917) 830-2525
• ✉️ Contact QuickRx Specialty Pharmacy

Authoritative Medical Resources:

For reliable information about imatinib, generic drugs, and biosimilars, these authoritative resources are a good starting point:

• FDA – Generic Drug Facts
• FDA – Biosimilar and Interchangeable Biologics
• MedlinePlus – Imatinib
• National Cancer Institute – CML Treatment Information
• FDA – Understanding Generic Drugs

References

1. Gleevec (imatinib mesylate) Prescribing Information. Novartis Pharmaceuticals Corporation.
2. Imatinib (Lexi-Drugs). UpToDate/Lexicomp. Clinical and manufacturer data accessed 2026.
3. U.S. Food and Drug Administration. Generic Drug Facts.
4. U.S. Food and Drug Administration. Biosimilar and Interchangeable Biologics.
5. MedlinePlus. Imatinib.

Gleevec® is a registered trademark of Novartis AG. QuickRx Specialty Pharmacy is not affiliated with Novartis or any pharmaceutical manufacturer. We are an independent specialty pharmacy dedicated to helping patients afford their medications.